CytoSorbents Announces Publication of U.S. CTC Multicenter Registry Results Using CytoSorb® in Critically Ill COVID-19 Patients on Extracorporeal Membrane Oxygenation (ECMO)
- Monday, December 20, 2021, 7:15
- Environment
- Add a comment
MONMOUTH JUNCTION, N.J., Dec. 20, 2021 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces the…
About the Author
adminasapcorp has written 41677 stories on this site.